1. Academic Validation
  2. Revealing Functional Hotspots: Temperature-Dependent Crystallography of K-RAS Highlights Allosteric and Druggable Sites

Revealing Functional Hotspots: Temperature-Dependent Crystallography of K-RAS Highlights Allosteric and Druggable Sites

  • bioRxiv. 2025 Feb 28:2025.02.27.639303. doi: 10.1101/2025.02.27.639303.
Samuel L Deck 1 2 Megan Xu 1 2 Shawn K Milano 1 2 Richard A Cerione 1 2
Affiliations

Affiliations

  • 1 Department of Chemistry and Chemical Biology, Cornell University, Ithaca, NY 14853.
  • 2 Department of Molecular Medicine, Cornell University, Ithaca, NY 14853.
Abstract

K-Ras mutations drive oncogenesis in multiple cancers, yet the lack of druggable sites has long hindered therapeutic development. Here, we use multi-temperature X-ray crystallography (MT-XRC) to capture functionally relevant K-Ras conformations across a temperature gradient, spanning cryogenic to physiological and even "fever" conditions, and show how cryogenic conditions may obscure key dynamic states as targets for new drug development. This approach revealed a temperature-dependent conformational landscape of K-Ras, shedding light on the dynamic nature of key regions. We identified significant conformational changes occurring at critical sites, including known allosteric and drug-binding pockets, which were hidden under cryogenic conditions but later discovered to be critically important for drug-protein interactions and inhibitor design. These structural changes align with regions previously highlighted by large-scale mutational studies as functionally significant. However, our MT-XRC analysis provides precise structural snapshots, capturing the exact conformations of these potentially important allosteric sites in unprecedented detail. Our findings underscore the necessity of advancing tools like MT-XRC to visualize conformational transitions that may be important in signal propagation which are missed by standard cryogenic XRC and to address hard-to-drug targets through rational drug design. This approach not only provides unique structural insights into K-Ras signaling events and identifies new potential sites to target with drug candidates but also establishes a powerful framework for discovering therapeutic opportunities against Other challenging drug targets.

Keywords

Allosteric Sites; Cancer Therapeutics; Conformational Landscape; Cryogenic vs. Physiological Conditions; Drug Targeting; GTP/GDP Binding; GTPase; Inhibitor Design; K-RAS; K-RAS Mutants (G12C, G12D); Molecular Mechanisms; Multi-temperature X-ray Crystallography (MT-XRC); Oncogenic Mutations; Protein Conformational Dynamics; Room Temperature Crystallography; Signal Transduction; Small GTPases; Structural Biology; Structural Plasticity; Temperature-Dependent Flexibility.

Figures
Products